Your session is about to expire
← Back to Search
Kisspeptin for Reproductive Disorders
Study Summary
This trial is looking at whether a hormone called kisspeptin can help researchers understand reproductive disorders.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2009 Phase 2 trial • 36 Patients • NCT00586898Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- People with problems related to their ability to have children.I am a healthy woman aged 50-60, postmenopausal, and tested negative for Factor V Leiden if needed.People who are in good health.I have high prolactin levels and agree to stop my current dopamine agonist treatment.I am willing to undergo extra tests if required.I am a healthy woman, aged 21-40, not pregnant or breastfeeding, with regular menstrual cycles, no signs of high male hormones, and no Factor V Leiden mutation if tested.I am over 18, have a reproductive disorder, and haven't taken meds affecting it except for treatment.I have a reproductive disorder and have had a severe medication reaction or a confirmed pituitary tumor.I am a healthy man, 21-40, with normal sexual and testicular function.I have been diagnosed with hypogonadotropic hypogonadism.I am a healthy woman who has gone through menopause.My puberty started and progressed normally.I have been diagnosed with low hormone levels affecting my reproductive system.I have a reproductive disorder.I do not use illegal drugs and drink less than 10 alcoholic drinks a week.Women with Polycystic Ovarian Syndrome (PCOS) confirmed by a doctor, with extra tests if necessary.I am healthy, with normal puberty development, no chronic diseases, and haven't taken prescription meds recently.I am willing to undergo extra tests if required.You are a healthy person who had a serious reaction to a medication in the past.I am a healthy postmenopausal woman with high androgen levels, unable to stop hormone therapy if needed.You are healthy and don't use illegal drugs or drink too much alcohol. You haven't had a serious reaction to medication before, and your physical exam and lab tests are normal.I have normal sexual function and no reproductive health issues.
- Group 1: kisspeptin, GnRH
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the Food and Drug Administration accepted GnRH for use in medicine?
"The lack of data confirming GnRH's safety and efficacy results in a score of 1 on our team at Power's scale. This is indicative that this is an early-phase trial."
What is the cap on enrollment in this clinical trial?
"Affirmative. Clinicaltrials.gov has information that attests to this medical trial being in the process of patient recruitment, which commenced on March 1st 2009 and was most recently updated on June 29th 2022. The study seeks 496 volunteers from a single site."
Are there any available slots still unoccupied in this experiment?
"Indeed, according to clinicaltrials.gov this research endeavor is actively recruiting participants and was initially posted on March 1st 2009. The trial most recently updated its information on June 29th 2022 and requires 496 patients from one location to enroll in the study."
What former experiments have utilized GnRH in the past?
"As of today, 46 separate clinical trials researching GnRH are ongoing with 10 in Phase 3. Of the 1321 locations conducting studies on the subject, several can be found within Chicago, Illinois."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger